Senior insider sale
Chief Financial Officer at CLEARSIDE BIOMEDICAL, INC. — senior position signals high conviction
$16.5K
12.90K shares
What this filing means
DEIGNAN CHARLES A. plans to sell 12.90K shares of CLEARSIDE BIOMEDICAL, INC. valued at approximately $16.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/19/2024ACC: 0001969223-24-000010
Officer· Chief Financial Officer
Since Feb 2019
12.90K
Shares to sell
$16.5K
Approx. market value
24.09K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU vest
cash
1/18/2024
24.09KTotal acquired24.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/18/2024 | RSU vest cash | 24.09K | — |
| Total | 24.09K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
12.90K
Market value
$16.5K
1/19/2024
Total
Units
12.90K
Value
$16.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/19/2024 | 12.90K | $16.5K | Nasdaq | Planned |
| Total | 12.90K | $16.5K | ||